Oct 26, 2024 · CDC recommends pneumococcal vaccination for children younger than 5 years and adults 50 years or older. CDC also recommends pneumococcal vaccination for children and adults at increased risk for pneumococcal disease.

Oct 26, 2024 · CDC recommends pneumococcal vaccination for many adults based on age, having certain risk conditions, and pneumococcal vaccines already received. Talk to a healthcare provider about what's best for your specific situation. In the United States, there are 2 types of vaccines recommended to help prevent pneumococcal disease in adults:

Oct 26, 2024 · CDC recommends pneumococcal vaccination for people based on their age or if they have certain risk conditions. Pneumococcal vaccines are the best way to protect against serious pneumococcal infections. Talk to a vaccine provider if you have questions about pneumococcal vaccines.

Enter a patient's age, pneumococcal vaccination history, and underlying medical conditions. Move through this tool to create customized pneumococcal vaccination recommendations.

Feb 1, 2025 · The CDC has lowered the recommended age for healthy adults to receive a pneumococcal vaccine to 50 from 65. The agency now also recommends a second dose of the 2024–25 COVID vaccine, to be taken six months after the first dose, for people 65 and older and those who have a moderately or severely compromised immune system.

This report compiles and summarizes all published recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults aged ≥19 years in the United States.

Pneumococcal ACIP Vaccine Recommendations. Recommended Immunization Schedule for Adults. Recommended Immunization Schedule for Children and Adolescents. Pneumococcal Vaccination: Information for Healthcare Professionals. Pneumococcal Vaccine Timing for Adults (PDF) Pneumococcal Vaccine Shared Clinical Decision-Making for Adults (PDF)

For adults with an immunocompromising condition, cochlear implant, or CSF leak, the minimum interval for PPSV23 is ≥8 weeks since last PCV13 dose and ≥5 years since last PPSV23 dose; for others, the minimum interval for PPSV23 is ≥1 year since last PCV13 dose and ≥5 years since last PPSV23 dose.

Oct 24, 2024 · For the first time, the Centers for Disease Control and Prevention has lowered the recommended age for those who should get a pneumococcal vaccine — down to 50, from 65.

Make sure your patients are up to date with pneumococcal vaccination. Together, with the patient, vaccine providers may choose to administer PCV20 to adults ≥65 years old who have ≥5 years PCV20 already received PCV13 (but not PCV15 or PCV20) at any age and PPSV23 at or after the age of 65 years old.